

QUICK LINKS
A intermediate of the metabolite of Atorvastin, a competitive, selective HMG-CoA reductase inhibitor. Atorvastin is the only drug in its class specfically indicated for lowering both elevated LDL-cholesterol and triglycerides in patients with hypercholesterolemia.
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
N-2-Benzyloxyphenyl α-Benzilidene Isobutyrylacetamide, 50 mg | sc-207941 | 50 mg | $360.00 |